Clinical Trial Update: Accelerated Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Pulse or Continuous UV-A Light [Phase 3]

View source ↗

Summary

Phase 3 trial update on accelerated corneal collagen crosslinking using pulse or continuous UV-A light for keratoconus and corneal ectasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ectasia
• Keratoconus

Drugs mentioned

• accelerated corneal collagen crosslinking (CXL) with UV-A light

Snippet

Sponsor: Cornea and Laser Eye Institute | Conditions: Keratoconus, Corneal Ectasia | Phase 3 | Status: UNKNOWN